McMurray, J. J. V. Et Al. 2013. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). EUROPEAN JOURNAL OF HEART FAILURE , vol.15, no.9 , 1062-1073.

McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., ... Rouleau, J.(2013). Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). EUROPEAN JOURNAL OF HEART FAILURE , vol.15, no.9, 1062-1073.

McMurray, Hasan Et Al. "Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)," EUROPEAN JOURNAL OF HEART FAILURE , vol.15, no.9, 1062-1073, 2013

McMurray, Hasan Et Al. "Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)." EUROPEAN JOURNAL OF HEART FAILURE , vol.15, no.9, pp.1062-1073, 2013

McMurray, J. J. V. Et Al. (2013) . "Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)." EUROPEAN JOURNAL OF HEART FAILURE , vol.15, no.9, pp.1062-1073.

@article{article, author={Hasan KUDAT Et Al. }, title={Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)}, journal={EUROPEAN JOURNAL OF HEART FAILURE}, year=2013, pages={1062-1073} }